- MVP Templates
- Posts
- The Scrappy Startup Story that Launched Oracle's $400B Empire
The Scrappy Startup Story that Launched Oracle's $400B Empire
How Larry Ellison built Oracle using IBM's own discoveries against them
Branden Coluccio
October 07, 2025
In partnership with
The Gold standard for AI news
AI keeps coming up at work, but you still don't get it?
That's exactly why 1M+ professionals working at Google, Meta, and OpenAI read Superhuman AI daily.
Here's what you get:
Daily AI news that matters for your career - Filtered from 1000s of sources so you know what affects your industry.
Step-by-step tutorials you can use immediately - Real prompts and workflows that solve actual business problems.
New AI tools tested and reviewed - We try everything to deliver tools that drive real results.
All in just 3 minutes a day
📍 Santa Clara, California
In 1977, Larry Ellison was facing a problem that would make most entrepreneurs abandon their business model: IBM dominated 70% of all enterprise computing and showed no interest in sharing their System R database technology with competitors.
While working at Ampex Corporation, Ellison had discovered Edgar F. Codd's revolutionary paper on "relational databases"—a concept IBM had invented but refused to commercialize.
That's when Ellison made a bet that seemed impossible: he could out-execute IBM using their own research.
With just $2,000 in startup capital ($1,200 of it his own money), he convinced co-founders Bob Miner and Ed Oates to build what IBM wouldn't: a commercial relational database system.
By 1979, their CIA contract for "Oracle" database proved the concept worked.
Today, Oracle's $400+ billion market cap and dominance of enterprise databases proves that sometimes the best strategy is building what incumbents are too scared to release.
The Play: Academic Research + Unrelenting Confidence
While most startups tried to invent new technology from scratch, Ellison took the opposite approach.
He used IBM's own published research as the blueprint for Oracle's product strategy, betting that corporate bureaucracy would prevent IBM from commercializing their breakthrough discoveries quickly enough.
Key Strategic Moves:
Codd's Paper as Product Roadmap: Used Edgar Codd's IBM research on relational databases as Oracle's technical specification before IBM released a commercial product.
CIA as Proof-of-Concept Customer: Secured government contract using "Oracle" codename, providing credible reference customer for enterprise sales.
Early Market Entry: Launched Oracle Version 2 in 1979 (skipped Version 1 to appear mature) while IBM was still debating whether to cannibalize existing products.
The Results:
🚀 $2,000 startup capital from three founders was sufficient to build initial product using borrowed VAX machines
🚀 $2M Series A funding from Don Lucas after proving CIA contract validated enterprise database demand
🚀 $400B market cap today, making Oracle the world's #2 enterprise software company behind Microsoft
The Tactical Genius Behind Ellison's IBM Rebellion
1. Corporate Bureaucracy as Competitive Moat
IBM's size became Oracle's advantage. While IBM worried about cannibalizing their existing database products, Oracle could focus entirely on relational technology.
Ellison positioned this bureaucratic paralysis as Oracle's primary competitive window—they could move fast while IBM moved slowly.
2. Academic Paper as Investment Thesis
Ellison didn't need expensive market research—he had Codd's peer-reviewed IBM paper proving relational databases were superior to hierarchical systems.
This gave investors scientific validation for Oracle's technical approach while showing IBM had already solved the hard research problems.
3. Government Contract as Enterprise Credibility
The CIA contract wasn't just revenue—it was enterprise validation.
When pitching VCs and Fortune 500 customers, Oracle could claim they powered America's most sensitive intelligence operations.
This government reference eliminated technical risk concerns from enterprise buyers.
💡 How to Steal Oracle’s Playbook
1. Mine Academic Research for Commercial Opportunities
Monitor university and corporate research labs for breakthrough technologies that aren't being commercialized
Use peer-reviewed papers as validation for your technical approach rather than conducting expensive R&D
Look for technologies invented by large companies that are too bureaucratic to bring to market quickly
2. Turn Incumbent Advantages Into Competitive Disadvantages
Identify ways that market leaders' size, complexity, or existing products prevent them from adopting new approaches
Position your startup's focus and speed as superior to incumbent's resources and market position
Show investors how established players' success creates blind spots your startup can exploit
3. Launch Before Incumbents Can Respond
Move fast to establish market position while large competitors debate strategy internally
Use first-mover advantage to capture early enterprise customers before incumbents wake up
Show investors how timing advantages create sustainable competitive moats
Startups Currently Raising from Around the World
Are you ready to be featured on this list?
Sunhat (Germany): AI-powered ESG data platform that automatically validates and shares sustainability and compliance information for enterprises, helping companies respond to thousands of monthly requests for policies, certificates, and ESG metrics from customers, investors, and regulators.
🔗 getsunhat.com
📄 Funding Announcement
💰 Raising: €9.2M ($10.8M) (Series A) | Committed: Fully raised (October 2025; led by CommerzVentures with participation from Capnamic, EnBW New Ventures, xdeck, and WEPA Ventures)
Light (Denmark): AI-native finance platform that automates multinational accounting, bookkeeping, payments, expense management, and financial reporting for fast-growing technology companies, enabling them to run global finance operations from a single system.
🔗 light.inc
📄 Funding Announcement
💰 Raising: $30M (Series A) | Committed: Fully raised (September 2025; led by Balderton Capital with participation from Atomico, Cherry Ventures, Seedcamp, and Entrée Capital)
Midi Health (USA): Virtual women's health platform specializing in perimenopause, menopause, and midlife care, providing personalized treatment plans that include hormonal, non-hormonal, and lifestyle-based solutions covered by most PPO insurance plans.
🔗 joinmidi.com
📄 Funding Announcement
💰 Raising: $50M (Series C) | Committed: Fully raised (October 2025; led by Advance Venture Partners, bringing total funding to $150M with a $150M revenue run rate)
Takeaway:
Larry Ellison didn't just build a database company—he pioneered the strategy of using incumbent research against incumbents themselves.
By taking IBM's own academic discoveries and commercializing them faster than IBM's bureaucracy could move, Oracle captured the enterprise database market before the inventor could compete.
His $2,000 investment became a $400B empire because he understood that sometimes the best technology strategy isn't innovation—it's execution speed.
For founders, the lesson is clear: The biggest opportunities often exist in the gap between corporate research and corporate execution. Sometimes the best way to beat giants isn't by being smarter—it's by being faster to market with their own ideas.
Want to build the next enterprise giant? Look for breakthrough research that large companies are too slow or scared to commercialize, then execute before they realize their mistake.
Build Aggressively.
— Forbes 30 under 30 | Top 5% Inc. 5,000 Entrepreneur | $100M+ in exits
📩 PS: Was this helpful? Hit reply to let us know & share your startup story—we’d love to hear it!
📩 PSS: Do you want help raising money and scaling you business? Click here set up a meeting!
What'd you think of this post? |